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httpPseudoaneurysm of the thoracic aorta as an
unprecedented complication of esophageal stenting
Sara Gonzalez Sanchez, MD, Isaac Martinez Lopez, PhD, Servando F. Diez, MD, and
Francisco Javier Serrano Hernando, MD, Madrid, SpainEsophageal stenting is a signiﬁcant advance in the palliative treatment of obstructive
esophageal tumors.1 However, reintervention during follow-up is often needed due
to intrastent restenosis, with other complications being much less common.1 We
describe the case of a patient with erosion of the aortic wall caused by an esophageal
stent. The patient gave consent for the publication of his data.
A 50-year-old man with a history of smoking was examined due to dry cough,
asthenia/anorexia, and thoracic pain during the past month. A computed tomography
scan detected a 5-cmmass with irregular borders and contralateral nodules in the para-
hilar right lung. The histologic diagnosis was a moderately differentiated, stage IV,
squamous cell lung carcinoma.
After neoadjuvant chemotherapy, the patient developed dysphagia for solids. An
oral panendoscopy revealed an ulcerated vegetant lesion in the esophagus, with
a histologic diagnosis of a squamous cell lung carcinoma.
Two 12-cm Ultraﬂex esophageal stents (Boston Scientiﬁc, Natick, Mass) were
implanted to give an esophageal lumen of 28 mm (A). However, the 2-month follow-
up computed tomography scan revealed a 2-cm pseudoaneurysm of the descending
thoracic aorta associated with erosion of the wall by the proximal end of the esophageal
endoprosthesis (B). Through a right transfemoral approach, the pseudoaneurysm was
excluded using a 28-mm 100-mmTAG aortic endoprosthesis (W. L. Gore & Associ-
ates, Flagstaff, Ariz), distal to the subclavian artery, with an excellent angiographic result
(C and D). Six months later, the patient died of acute respiratory failure.
Esophageal stenting is a minimally invasive, useful option for the symptomatic treat-
ment of dysphagia and malnutrition in patients with nonoperable malignant stenosis.1
Among the late complications reported, erosion of the aortic wall by the stent and
the development of a pseudoaneurysm is unprecedented and especially surprising for
the use of a low-radial-strength stent such as the Ultraﬂex.2 The only similar case we
are aware of in the literature is one of an aortoenteric ﬁstula as a late complication of
a duodenal stent that was successfully resolved by endovascular treatment.3 Owing to
its minimally invasive nature, endovascular aortic repair has provided excellent outcomes
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